References
Richette P, Bardin T (2010) Gout. Lancet 375:318–328
Doherty M, Jansen TL, Nuki G, Pascual E, Perez-Ruiz F et al (2012) Gout: why is this curable disease so sldom cured? Ann Rheum Dis 77:1765–1770
Kuo CF, Grainge MJ, Mallen C, Shang W, Doherty M (2014) Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. doi:10.1136/annrheumdis-2013-204463
Singh JA (2014) Facilitators and barriers to adherence to rate-lowering therapy in African-Americans with gout. Arthritis Res Ther 16:R82. doi:10.1186/ar4524
Acknowledgments
The patient from Fig. 2 is gratefully acknowledged for his cooperation; he has passed already years ago.
Disclosures
The author has participated in advisory boards with Abbvie, Astra/Zeneca, BMS, Janssen, Menarini, Novartis, Roche and UCB and has reveived research grants from Abbvie and UCB.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jansen, T.L. Gout: cartoonized and bagatellized and still left untreated. Time to change. Clin Rheumatol 34, 1317–1319 (2015). https://doi.org/10.1007/s10067-015-2986-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-015-2986-y